GS
Graig Suvannavejh Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
53%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
75.8%
Neutral
24.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $20 |
51%
downside
| 5 | – |
–
| 5 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $250 |
125%
upside
| 2 | +20% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $204 |
116%
upside
| 4 | +18% |
0
%
| 24 Feb ‘26 3 months ago |
|
|
|
Outperform
Upgraded
| $10 |
20%
upside
| 1 | +85% |
0
%
| 19 Feb ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $14 |
68%
upside
| 1 | +59% |
0
%
| 9 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $5 |
64%
downside
| 1 | +315% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $54 |
2%
upside
| 3 | +53% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Outperform
Upgraded
| $194 |
41%
upside
| 2 | +7.1% |
0
%
| 2 Dec ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $46 |
35%
upside
| 5 | -2.7% |
0
%
| 1 Dec ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $100 |
63%
upside
| 1 | -12% |
0
%
| 20 Nov ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $23 |
150%
upside
| 1 | -5.8% |
0
%
| 19 Nov ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $56 |
19%
downside
| 1 | – |
–
| 18 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $46 |
51%
upside
| 2 | +18% |
0
%
| 11 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $202 |
20%
downside
| 2 | +15% |
0
%
| 6 Nov ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $4 |
245%
upside
| 1 | – |
–
| 12 Sep ‘25 9 months ago |
|
|
|
Outperform
Initiated
| $30 |
991%
upside
| 1 | -98% |
0
%
| 8 Sep ‘25 9 months ago |
|
|
|
Outperform
Upgraded
| $3.50 |
145%
upside
| 1 | +27% |
0
%
| 28 Jul ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $5 |
317%
upside
| 1 | +106% |
0
%
| 16 Jul ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $12 |
175%
upside
| 1 | +65% |
0
%
| 26 Jun ‘25 11 months ago |
|
|
|
Neutral
Downgraded
| $0.5000 |
811%
upside
| 1 | -63% |
–
| 26 Jun ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $10 |
141%
upside
| 1 | +173% |
0
%
| 18 Jun ‘25 12 months ago |
|